1. Home
  2. CPS vs AVTX Comparison

CPS vs AVTX Comparison

Compare CPS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cooper-Standard Holdings Inc.

CPS

Cooper-Standard Holdings Inc.

N/A

Current Price

$17.61

Market Cap

376.2M

ML Signal

N/A

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

N/A

Current Price

$6.76

Market Cap

426.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CPS
AVTX
Founded
1960
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
376.2M
426.2M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
CPS
AVTX
Price
$17.61
$6.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
14
Target Price
$25.00
★ $34.80
AVG Volume (30 Days)
348.8K
★ 2.9M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.87
72.07
EPS
N/A
★ N/A
Revenue
N/A
★ $27,813,137.00
Revenue This Year
$3.62
N/A
Revenue Next Year
$4.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 2312.27
52 Week Low
$16.91
$6.53
52 Week High
$47.98
$24.27

Technical Indicators

Market Signals
Indicator
CPS
AVTX
Relative Strength Index (RSI) 37.97 33.14
Support Level $16.91 $6.53
Resistance Level $31.78 $8.55
Average True Range (ATR) 1.18 0.64
MACD -0.05 0.23
Stochastic Oscillator 12.45 10.40

Price Performance

Historical Comparison
CPS
AVTX

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Share on Social Networks: